Genetic and transcriptional evolution alters cancer cell line drug response

2018/08/01 by Uri Ben‐David, Uri Ben-David, Benjamin Siranosian +34 · 12 citations
Biochemistry, Genetics and Molecular Biology · #Cancer Genomics and Diagnostics #Gene expression and cancer classification #Single-cell and spatial transcriptomics

paper · doi:10.1038/s41586-018-0409-3

Citations

• Systematic identification of genomic markers of drug sensitivity in cancer cells

Cited by

• Construction of an atlas of transcription factor binding during mouse development identifies popular regulatory regions
• Characterizing the evolutionary dynamics of cancer proliferation in single-cell clones with SPRINTER
• A GCN1-independent activator of the kinase GCN2
• The Hallmarks of Predictive Oncology
• Conditionally Reprogrammed Cells as Preclinical Model for Rare Cancers
• Organoid models for translational pancreatic cancer research
• Context-dependent genetic interactions in cancer
• The exercise IL-6 enigma in cancer
• PIKfyve inhibition in MM disrupts autophagy and lysosome function, increasing MHC expression and cholesterol metabolism
• Genetically tractable embryonic cell lines from sea urchins Lytechinus variegatus and Strongylocentrotus purpuratus
• A blood-based DNA damage signature in patients with Parkinson’s disease is associated with disease progression
• Connecting chemical structure to single cell signaling profiles